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Introduction
Bioinorganic chemistry offers surplus opportunities for the design and making of pharmaceutical drugs that are not accessible to organic molecules [1] [2] [3] [4] . Since the approval of cisplatin for the treatment of cancer, a number of other metal complexes has been investigated for their therapeutic potential [5, 6] . Among them, transition metal complexes of thiosemicarbazone ligands have received considerable interest due to their inhibition of DNA synthesis caused by a modification in the reductive conversion of ribonucleotides to deoxyribonucleotides [7] . In general, it has been observed that the biological activity of the complexes of thiosemicarbazones is greater than that of the corresponding free thiosemicarbazones [8] [9] [10] [11] [12] . Reactions of various thiosemicarbazones [7, [13] [14] [15] [16] [17] and semicarbazones [18] with diverse transition metal ions lead to the formation of metal complexes which have shown valuable biological activities. In particular, heterocyclic thiosemicarbazone complexes have aroused considerable interest in bioinorganic chemistry because of their pharmacological properties, particularly as antiphrastic, antibacterial, antioxidant and antitumoral agents [8, 19, 20] . For example, Ni(II) complexes with 6-methoxy-2-oxo-1,2-dihydroquinoline-3-carbaldehyde-based N-substituted thiosemicarbazones showed significant antioxidant and cytotoxicity [21] .
Indole skeleton is present in the structure of many natural products with high structural complexities and biologically active molecules [22] . For this reason, indole and indole derivatives have been used, continuously, in different research areas such as pharmaceuticals, fragrances, agrochemicals, pigments and materials science [23] . One of the most important indole derivatives is an essential amino acid, tryptophan and it is one of the naturally occurring amino acids. Tryptophan-containing proteins have reducing effect on depression and insomnia related with hormonal fluctuations [24] . Research on indole-3-carbinol has been conducted using laboratory animals and cultured cells, which showed that it can prevent the binding of aflatoxin to DNA and hence it reduces the carcinogenic effects of aflatoxins [25] [26] [27] . Indole-3-carbinol was also effective in the prevention of breast and skin cancers [28, 29] . There are many drugs whose structures contain the indole nucleus, including sumatriptan, a tryptamine derivative [30] used in the treatment of migraine headaches, indomethacin and etodolac [31] , which are used as non-steroidal anti-inflammatory drugs, and pindolol, a β-adrenoceptor antagonist [32] . These stem a great interest to develop indole-based thiosemicarbazone complexes for biological applications. Herein, we present the synthesis, structure, DNA binding, DNA cleavage, protein binding, DNA/protein molecular docking, antioxidant, antihaemolytic and cytotoxic studies of Ni(II) complexes containing indole-3-carbaldehyde-N-substituted thiosemicarbazones.
Experimental General methods
All the chemicals were purchased from Sigma-Aldrich/ Merck and used as received. Solvents were purified according to the standard procedures.
Physical measurements
Elemental analyses were done using a Vario EL-III CHNS analyser. FT-IR spectra were obtained as KBr pellets using a Nicolet-iS5 spectrophotometer. UV-visible spectra were recorded using a Shimadzu-2600 spectrophotometer. Emission spectral studies were carried out with a Jasco V-630 spectrophotometer using 5% DMF in buffer as the solvent. 1 H and 13 C NMR spectra were recorded on a Bruker 400 and 100 MHz spectrometer, respectively. MS-ESI spectra were recorded using a high-resolution JEOL and Q-Tof mass spectrometer.
Synthesis of thiosemicarbazones (L1-L4)
3-Indole aldehyde and the substituted thiosemicarbazide were combined (1:1) in ethanol (15 mL) in the presence of acetic acid (1-2 drops). The mixture was refluxed for 3 h, during which a white precipitate appeared. Then, the mixture was allowed to cool to room temperature and solid was filtered off. The product was washed with cold ethanol and purified by recrystallization from a methanoldichloromethane mixture (1:2). The compounds were subsequently crystallized from acetonitrile-methanol mixture (1:1). 
(E)-2-((1H-indol-3-yl)methylene) hydrazinecarbothioamide (L1)

Synthesis of Ni(II) complexes (1-4)
The ethanolic solution of NiCl 2 ·6H 2 O (1 mmol) was added into the solution of an appropriate indole-based thiosemicarbazone ligand (1 mmol) in ethanol and a few drops of triethyl amine were added. The reaction mixture was stirred for 3 h under reflux, and then the precipitate formed was filtered and washed with ethanol. The suitable crystals for X-ray diffraction were grown from CH 2 Cl 2 -DMF mixture (2:1). 
Bis[(E)-2-((1H-indol-3-yl)methylene) hydrazinecarbothioamide]Ni(II) (1)
Single crystal X-ray crystallography
Single crystal X-ray diffraction data were collected using Bruker APEX2 (L4, 2, 3 and 4) and Bruker GADDS (L3) X-ray (three-circle) diffractometer. The X-ray radiation employed was generated from a Mo sealed X-ray tube (K α = 0.70173 Å) for the former and Cu sealed X-ray tube (K α = 1.5418 Å) fitted with a graphite monochromator in the parallel mode (175 mm collimator with 0.5 mm pinholes) for the latter. Sixty data frames were taken at widths of 0.5°. These reflections were used in the autoindexing procedure to determine the unit cell. A suitable cell was found and refined by nonlinear least squares and Bravais lattice procedures. Integrated intensity information for each reflection was obtained by reduction of data frames with APEX2 [33] . SADABS was employed to correct the data for absorption effects [34] . The structures were solved by direct methods SHELXTL (XS), and refined (SHELX-97, weighted least squares refinement on F 2 ) using APEX2 and OLEX2 [35, 36] . Hydrogen atoms were placed in idealized positions and were set riding on the respective parent atoms. All non-hydrogen atoms were refined with anisotropic thermal parameters. The structures were refined (weighted least squares on F 2 ) to convergence [35] . Olex2 was employed for the final data presentation and structure plots [36] . The crystallographic data and the results of refinements are summarized in Tables 1, 2 , S1 and S2.
DNA binding experiments
For DNA absorption spectral studies, DNA samples were dissolved in 50 mM NaCl/5 mM Tris-HCl (pH 7.2) solution. CT-DNA solution displayed a UV absorbance ratio at 260 and 280 nm (A260/A280) of ca. 1.9:1, indicating that the CT-DNA was sufficiently in protein-free form [37] . The concentration of the nucleic acid solutions was determined by UV absorbance at 260 nm after 1:100 dilutions. The extinction coefficient at 260 nm was taken as 6600 M −1 cm −1 [38] . Stock solutions were stored at 4 °C and used within 4 days. Concentrated stock solutions were prepared by dissolving calculated amounts of the complexes (1, 2, 3 and 4) in a 5% DMF/5 mM TrisHCl/50 mM NaCl buffer to required concentrations for all the experiments. Absorption spectral titration experiments were performed by maintaining a constant concentration of the complex and varying the nucleic acid concentration (0-35 μM). The spectra were recorded after equilibration for 3 min, allowing the compounds to bind to the CT-DNA.
The competitive studies of each complex with ethidium bromide (EB) have been investigated using fluorescence spectroscopic technique. The excitation wavelength was fixed, and emission range was adjusted before measurements. DNA was pretreated with EB in the 1:1 ratio for 15 min. The complexes were then added to this mixture, and their effect on the emission intensity was measured. The Stern-Volmer equation was used to evaluate the apparent binding constant (K app ) and quenching constant (K q ) values of the complexes. The changes in fluorescence intensities at 596 nm (510 nm excitation) of EB bound to DNA were recorded with an increasing amount of the complexes until maximum reduction in the intensity of fluorescence occurred.
Viscosity experiments were carried out using a semimicroviscometer maintained at 27 °C in a thermostatic water bath. DNA samples (0.5 mM) were prepared by sonication to minimize complexities arising from DNA flexibility [39] . [40] [41] [42] . CD spectroscopic technique is useful in monitoring the conformational changes induced by the interaction of drugs with the DNA helix. The B-form conformation of DNA showed two consecutive CD bands in the UV region, a positive band at 275 nm is due to base stacking and a negative band at 245 nm is due to polynucleotide helicity. CD spectra of DNA in the absence and presence of the complexes was recorded with a J-715 spectropolarimeter (Jasco) at 25 °C with a 0.1 cm path length cuvette. The spectra were recorded for 20 μM of DNA in the absence and presence of 5 μM of the Ni(II) complexes (1) (2) (3) (4) in the region 220-300 nm [43] . Index ranges Goodness-of-fit on F 
DNA cleavage experiment
A mixture of Tris buffer (5 mM Tris-HCl/50 mM NaCl buffer, pH 7.2), pUC19 plasmid DNA (150 μg/mL) and different amounts of the complexes was incubated for 4 h at 37 °C. A dye solution (0.05% bromophenol blue and 5% glycerol) was added to the reaction mixture prior to electrophoresis. The samples were then analysed by 1.5% agarose gel electrophoresis [Tris HCl/Boric acid/EDTA (TBE) buffer, pH 8.0] for 3 h at 60 mV. The gel was stained with 0.5 μg mL −1 EB, visualized by UV light, and photographed. The extent of cleavage of the pUC19 DNA was determined by measuring the intensities of the bands using Alpha Imager HP instrument.
Protein binding experiment
Quenching of the emission of tryptophan residues of BSA was performed using the complexes as quenchers. To a solution of BSA in phosphate buffer (pH 7.2), increments of the quenchers were added, and the emission signal at 341 nm (280 nm excitation) was recorded after each addition of the quencher. The excitation and emission slit widths and scan rates were constantly maintained for all the experiments. Concentrated stock solutions of the test compounds were prepared by dissolving them in DMF and diluted suitably with phosphate buffer to get required concentrations. 2.5 mL of BSA solution (1 μM) was titrated by successive additions of a 5 mL of stock solution of the test compounds (10 −4 M) using a micropipette. Synchronous fluorescence spectra were also recorded using the same concentration of BSA and the test compounds as mentioned above with two different Δλ (difference between the excitation and emission wavelengths of BSA) values such as 15 and 60 nm [44] .
Molecular docking studies
The X-ray crystal structure of B-DNA (PDB ID: 1BNA), dodecamer d(CGCGAATTCGCG) 2 human DNA Topo-I complex (PDB ID: 1SC7) and BSA (PDB ID: 3V03) was obtained from the Protein Data Bank (http://www. rcsb.org/pdb). 2D structure of the Ni(II) complexes was drawn using Chem Draw Ultra 12.0 (ChemOffice 2010). Chem3D Ultra 12.0 was used to convert 2D structure into 3D and the energy was minimized using semi-empirical AM1 method. Molecular docking studies have been done using the AutoDock Tools (ADT) version 1.5.6 and Auto Dock version 4.2.5.1 docking program [45]. The energy calculations were made using genetic algorithms. The outputs were exported to PyMol for visual inspection of the binding modes and for possible polar and hydrophobic interactions of the complexes with DNA and BSA.
Antioxidant assay
The antioxidant activity of the Ni(II) complexes was evaluated using the DPPH free radical scavenging assay [46, 47] . 5 mg of the each compound was dissolved in 1 mL of DMSO, which was maintained as a stock solution. From the stock, 25, 50, 75, 100, 250 and 500 µg of solutions were prepared. For the positive control, ascorbic acid at different concentrations (25, 50, 75 , 100, 250 and 500 µg) was used. 100 µL of DPPH (at 10 mM concentration) and 900 µL of methanol were added to different concentrations of the compounds and also to the positive control, to screen the antioxidant potential. 100 µL of DPPH was added to 100 µL of DMSO and 900 µL of methanol to reveal the scavenging effect of DMSO. 1 mL of methanol was added to 100 µL of DPPH, which was used as a negative control. The mixtures were shaken vigorously and allowed to stand for 30 min in dark, which were analysed for the absorbance at 517 nm by UV spectrometer.
Haemolysis assay
Human red blood cells (RBC) were isolated using the standard procedure [48] and diluted with 0.1 M phosphate buffer saline (PBS) (pH 7.2). To 0.5 mL of RBC solution, six different concentrations (25, 50, 75 , 100, 250 and 500 µg/mL) of the Ni(II) complexes were added to test the toxicity of the complexes. 100% lysis was initiated by adding 500 µL of H 2 O, which acted as a negative control. RBC samples without H 2 O and the Ni(II) complexes acted as a positive control. All the samples were incubated at 37 °C (19) for 30 min and centrifuged at 3000 rpm. The supernatant was used to analyse the percentage of lysis based on the absorbance at 560 nm.
In vitro cytotoxicity evaluation by MTT assay
Cytotoxicity of the Ni(II) complexes was carried out on lung cancer (A549), human breast cancer (MCF7) and mouse fibroblasts (L929) cell lines. Cell viability was carried out using the MTT assay [49] . The lung adenocarcinoma (A549), human breast (MCF7) cells and mouse fibroblasts (L929) were plated separately in 96-well plates at a concentration of 1 × 10 5 cells/well. Complexes (1-4) of concentration ranging from 1 to 500 µM dissolved in DMSO were seeded to the wells. DMSO was used as the control. After 24 h, the wells were treated with 20 μL of MTT [5 mg/mL PBS] and incubated at 37 °C for 4 h. The purple formazan crystals formed were dissolved in 200 μL of DMSO. The absorbance of the solution was measured at a wavelength of 570 nm using a Beckmann Coulter Elisa plate. Triplicate samples were analysed for each experiment. The percentage inhibition was calculated using the formula
Hoechst 33258 staining
Cell pathology was detected by staining the nuclear chromatin of trypsinized cells (4.0 × 10 4 mL −1 ) with 1 μL of Hoechst 33258 (1 mg/mL) for 10 min at 37 °C. Staining of suspension cells with Hoechst 33258 was used to view apoptotic changes. A drop of cell suspension was placed on a glass slide and a coverslip was laid over to reduce light diffraction. At random, 300 cells were observed in a fluorescent microscope fitted with a 377-355-nm filter and observed at 400× magnification, and the percentage of cells reflecting pathological changes was calculated [50] . 
Results and discussion
Synthesis
The thiosemicarbazone ligands (L1-L4) were synthesized via the typical condensation route from 3-indole aldehyde and appropriate thiosemicarbazides in the presence of glacial acetic acid (Scheme 1). Subsequently, the Ni(II) complexes (1-4) were prepared by heating the corresponding ligand with NiCl 2 ·6H 2 O (Scheme 2). The ligands and their Ni(II) complexes were characterized by elemental analyses and various spectroscopic techniques. The molecular structure of L3, L4, 2, 3 and 4 was confirmed by single crystal X-ray diffraction study.
Spectroscopy
The electronic spectra of the ligands showed two bands around 262-265 and 329-341 nm, which correspond to π-π* and n-π* transitions, respectively. The spectra of the complexes exhibited three bands in DMF solvent. Two bands appeared around 271-288 and 328-392 nm correspond to intraligand transitions. The band in the region 408-416 nm was attributed to ligand-to-metal charge-transfer (LMCT) transitions which indicated the formation of the complexes [17] .
In the FT-IR spectra of the ligands, three bands were observed for indole N-H, N-H (attached to azomethine) and N-H (attached to thiocarbonyl) in the range of 3448-3409, 3343-3300 and 3238-3169 cm −1 , respectively. The azomethine (C=N) and thiocarbonyl (C=S) stretching frequencies of the ligands were observed at 1567-1548 and 1299-1261 cm −1 , respectively. On complexation, there was a decrease in azomethine (1511-1500 cm −1 ) and thiocarbonyl (1263-1243 cm −1 ) stretching frequencies, which suggested the coordination of the ligands to Ni ion through azomethine nitrogen and thiocarbonyl sulphur [51] .
In the 1 H NMR spectra of the ligands, H-N-C=S proton resonated in the region 11.63-11.18 ppm. However, in Scheme 1 Synthetic route of indole-based N-substituted thiosemicarbazone ligands the spectra of the complexes (1-4), there was no resonance attributable to H-N-C=S, indicating the coordination of the ligands in the anionic form after deprotonation. The terminal N-H proton signal in the spectra of the ligands (L2-L4) and complexes was observed at 9.65-7.92 and 9.56-7.89 ppm, respectively. Two broad singlets were observed in the spectrum of L1 at 7.80 and 8.02 ppm corresponding to NH 2 protons. In the spectrum of 1, one broad singlet was observed at 6.92 ppm corresponding to NH 2 protons of the coordinated ligand. The signal of indole N-H proton in the ligands and complexes appeared at 11.72-11.61 and 12.17-11.92 ppm, respectively. The signals around 8.31-8.05 and 7.81-7.61 ppm in the spectra of the ligands correspond to azomethine CH and indole CH protons. In the spectra of the complexes, the azomethine CH and indole CH protons showed signals around 8.04-7.80 and 7.57-7.51 ppm, respectively. Further, a doublet was observed at 3.09 and 2.84 ppm in the spectra of L2 and 2, respectively, which was attributed to the presence of terminal CH 3 protons. 13 C NMR spectra of the ligands showed resonances due to C=S and C=N carbons in the regions 177.1-174.1 and 140.9-139.3 ppm, respectively. However, in the spectra of the complexes (1-4), C-S (after enolization and deprotonation) and C=N chemical shifts were observed at 174.7-173.2 and 147.2-141.1 ppm, respectively. Chemical shift of all other protons and carbons was observed in the expected regions [52] .
Single crystal X-ray crystallography
Thermal ellipsoid plot of the ligands (L3 and L4) and complexes (2, 3 and 4) with the atomic labelling scheme is shown in Figs. 1 and 2 . Crystal data and selected inter atomic bond lengths and angles are given in Tables 1, 2 Complexes 2, 3 and 4 crystallized in triclinic P-1 space group with Z of 1 (2 and 3) or 2 (4). The X-ray structure of 2, 3 and 4 showed a perfect square planar geometry with nitrogen and sulphur atoms coordinate to Ni ion in a trans fashion. One molecule of dimethyl formamide was found in the asymmetric unit of 2 and four molecules of the same solvent were found in the symmetric unit of 3. Two intramolecular hydrogen bonds were present between the azomethine H and S, which was rarely observed. The perfect square planar geometry was also reflected by τ 4 parameter [54, 55] . τ 4 can be calculated using the formula τ 4 = [360° − (α + ß)]/141°. The value of τ 4 ranges from 1.00 for a perfect tetrahedral geometry, since 360 − 2(109.5) = 141, to zero for a perfect square planar geometry, since 360 − 2(180) = 0. For the intermediate structure like trigonal pyramidal, τ 4 falls within the range of 0-1.00. In complexes 2, 3 and 4, the angles S(1)-Ni(1)-S(1)#1 and N(1)#1-Ni(1)-N(1) were 180° which revealed perfect square planar geometry. There was an increase in the C-N and C-S bond lengths and decrease in the N(2)-N(3) bond length in 2, 3 and 4 compared to L1, L3 and L4, respectively, which clearly attested the coordination of the ligand to Ni ion through azomethine N and thiocarbonyl 
DNA binding studies
DNA binding is the predominant property looked for in pharmacology when evaluating the potential of new anticancer complexes, and hence, the interaction between DNA and the complexes needs to be investigated. The mode and tendency of the binding of complexes 1-4 with CT-DNA were studied with different methods.
Electronic absorption titration
Before performing DNA interaction studies, the stability of the complexes was verified in physiological medium (Tris-HCl buffer solution with a pH value of 7.2, containing 5% DMF) by UV-visible spectroscopic technique. There were no obvious changes in either the intensity or the position of the absorption bands in Tris-HCl buffer solution compared to those in DMF alone, which suggested that the complexes are stable under physiological conditions. The electronic spectra of Ni(II) complexes (1-4) in Tris-HCl buffer/5% DMF exhibited two bands around 273-284 and 333-391 nm, which correspond to intraligand transitions. The observation of changes in this band upon incremental addition of CT-DNA was used to find out the binding constant. Complexes binding to DNA through intercalation usually results in hypochromism with or without a small red or blue shift, since the intercalative mode involves a strong stacking interaction between the planar aromatic chromophore and the base pairs of DNA [56, 57] . The interaction of complexes 1-4 was confirmed by the observed hypochromism with red shift (Figs. 3,  S1 ). The magnitude of hypochromism was in the order of 4 > 3 > 1 > 2, which reflected the DNA binding affinities of the complexes. The intrinsic binding constant K b was obtained from the ratio of slope to intercept in the plot of [DNA]/(ε a − ε f ) versus [DNA] according to the equation [58] 
where [DNA] is the concentration of DNA in base pairs, ε a is the apparent extinction coefficient value found by calculating A(observed)/[complex], ε f is the extinction coefficient for the free compound and ε b is the extinction coefficient for the compound in the fully bound form. Each set of data, when fitted into the above equation, gave a straight line with a slope of 1/(ε b − ε f ) and an y-intercept of 1/K b (ε b − ε f ) and the value of K b was determined from the ratio of slope to intercept (Fig. 4a) . The magnitudes of intrinsic binding constants (K b ) are given in . The high binding ability of complex 4 compared to the other complexes might be due to the presence of cyclohexyl ring at the terminal nitrogen atom of the coordinated ligand [21] .
EB displacement study
Fluorescence property has not been observed for the complexes at room temperature in solution or in the presence of CT-DNA. So the binding of the complexes with DNA could not be directly predicted through the emission spectra. Hence, competitive binding study was done to understand the mode of DNA interaction with the complexes [59] [60] [61] . EB is one of the most sensitive fluorescence probes that can bind with DNA [62] . The fluorescence of EB increases after intercalating into DNA. If the metal complex intercalates into DNA, it leads to a decrease in the binding sites of DNA available for EB, resulting in decrease in the fluorescence intensity of the CT-DNA-EB system [63] . The extent of decrease in the fluorescence intensity of CT-DNA-EB reflects the extent of interaction of the complex with CT-DNA. On adding the Ni(II) complexes (0-50 µM) to CT-DNA-EB, the quenching in the emission of DNA-bound EB took place (Figs. 3, S2 ) due to intercalation of the complexes with DNA. Fluorescence quenching is explained by the Stern-Volmer equation [64] Table 3 .
Viscosity measurements
Lengthening of DNA helix occurs on intercalation as base pairs are separated to accommodate the binding compound leading to increase in DNA viscosity. The values of relative specific viscosities of CT-DNA in the absence and presence of the compounds are plotted against [complex]/ [DNA]. The relative viscosities of CT-DNA bound to the complexes (1-4) increased with increasing the compound concentration (Fig. 4b ) similar to some known intercalators [65] , indicative of a classical intercalation. The ability of the complexes to increase the viscosity of DNA followed the order 4 > 3 > 1 > 2.
CD spectra
The CD spectrum of CT-DNA exhibited a positive band at 275 nm due to base stacking and a negative band at 245 nm due to helicity of B-DNA [66] . After the addition of 1-4, the spectrum showed an increase in positive and a decrease in negative ellipticity with a red shift of 6-4 nm. These alterations in the CD spectrum of DNA indicated strong conformational changes by the complexes [67] . It was observed that complex 4 showed significant changes in the CD spectrum compared to the other complexes (Fig. 4c) . Furthermore, the decrease in negative band is probably due to the unwinding of the DNA helix upon interaction with the complexes followed by transformation into A-like conformations [43, 68] . The CD results supported the order of binding ability of the complexes, obtained from other experiments.
Nuclease activity
To explore the DNA cleavage ability of the complexes (1-4), supercoiled (SC) pUC19 plasmid DNA (40 μM in base pairs) was incubated at 37 °C with the complexes (100 µM) in a 5% DMF/5 mM Tris-HCl/50 mM NaCl buffer at pH 7.2 for 4 h in the absence of external agent [69] . Complexes 1-4 cleaved SC (Form I) DNA into nicked circular (NC) (Form II) DNA (Fig. 4d) , and the DNA cleavage strength follows the order 4 (92.3%) > 3 (52.6%) > 1 (38.2%) > 2 (1.7%). The study revealed that 4 cleaved DNA more efficiently than the other complexes, because of the strong partial intercalation of the cyclohexyl ring at the terminal nitrogen atom [70] .
Protein binding studies Fluorescence and absorbance quenching of BSA by the Ni(II) complexes
Fluorescence spectra are useful in the qualitative analysis of the binding of chemical compounds to BSA. Generally, the fluorescence of BSA is caused by two intrinsic characteristics of the protein, namely tryptophan and tyrosine. The intrinsic fluorescence of BSA will provide considerable information on their structure and dynamics and is often utilized in the study of protein folding and association reactions. The interaction of BSA with the complexes was studied by fluorescence measurement at room temperature. A solution of BSA (1 µM) was titrated with various concentrations of the complexes 1-4 (0-20 µM). Fluorescence spectra were recorded in the range of 290-500 nm upon excitation at 280 nm. The changes observed in the fluorescence emission spectra of BSA on addition of increasing concentration of the Ni(II) complexes are shown in Figs. 5a and S3. On the addition of complexes 1-4 to BSA, there was a significant decrease in the fluorescence intensity of BSA at 345 nm up to 75.23, 71.47, 85.62 and 78.01%, respectively, from the initial fluorescence intensity of BSA accompanied by a hypsochromic shift of 10-15 nm. The observed blue shift is mainly due to the fact that the active site in protein is buried in a hydrophobic environment. These results indicated a definite interaction of all of the complexes with the BSA protein [71, 72] . The fluorescence (Fig. 6a) . When small molecules bind independently to a set of equivalent site, on a macromolecule, the equilibrium between free and bound molecules is repre- (Fig. 6a) , the number of binding site (n) and the binding constant (K b ) values have been obtained. K q , K b and n values for the interaction of the Ni(II) complexes with BSA are provided in Table 4 . The calculated value of n is around 1 for all of the compounds, indicating the existence of just a single binding site in BSA for all of the complexes. From the values of K q and K b , it was inferred that complex 4 interacted with BSA more strongly than the rest of the complexes. Here again, complex 4 showed better activity.
Quenching usually occurs either by dynamic or static mode. Dynamic quenching is a process in which the fluorophore and the quencher come into contact during the transient existence of the excited state. On the other hand, static quenching refers to the formation of a fluorophorequencher complex in the ground state [73] . A simple method to determine the type of quenching is UV-visible absorption spectroscopy. Addition of the complexes to BSA leads to an increase in BSA absorption intensity without affecting the position of absorption band (Fig. 6b) . It showed the existence of static interaction between BSA and the complexes due to the formation of the ground-state complex as reported earlier [74] .
Characteristics of synchronous fluorescence spectra
To investigate in detail the structural changes which occurred in BSA upon the addition of the new compounds, synchronous fluorescence spectra of BSA were measured before and after the addition of the test compounds. The results provided reasonable information on the molecular microenvironment, particularly in the vicinity of the fluorophore functional groups [74] . The difference between the excitation and emission wavelengths (Δλ) reflected the nature of the chromophore [62] . The large Δλ value (60 nm) is characteristic of tryptophan residue and a small Δλ value (15 nm) is characteristic of tyrosine. The synchronous fluorescence spectra of BSA with various concentrations of the complexes (1-4) were recorded at Δλ = 15 and 60 nm. On addition of the complexes, the fluorescence intensity of tryptophan residue at 340 nm decreased in the magnitude of 76.9, 81.3, 79.7 and 71.6% for complexes 1-4, respectively (Figs. 5b and S4 ). Similarly, there was also decrease in the intensity of tyrosine . Docked conformation was analysed in terms of energy, hydrogen bonding and hydrophobic interactions between the Ni(II) complexes and receptors to find the binding nature of the potent inhibitors. The compound-DNA interactions were carried out with the detailed analysis, and final coordinates of the compound and receptor were saved. To display the interaction of the complexes with the receptor binding site, output was exported to PyMol software and detailed analysis was done, the free energy of binding (FEB) of the compounds was calculated from the docking scores and details are shown in Table 5 .
In designing chemotherapeutic drugs, their interaction with DNA is vital to arrest the replication step in the cell cycle. DNA function can be suppressed in the physiological processes by the specific host-guest interaction between DNA and drugs. The metal complexes are widely used as the chemotherapeutic agents by destabilizing the DNA structure to block the cell functions.
We employed docking studies with the B-DNA (PDB ID: 1BNA) to predict the DNA binding affinity of the nickel(II) complexes. Ni (II) complexes 1, 2, 3 and 4 showed the binding energy values of −10.31, −9.72, −11.28, and −10.84 kcal/mol with two, four, three and three hydrogen bond interactions, respectively. Among all the complexes docked, 3 showed the lowest binding energy value of −11.28 kcal/mol with three hydrogen bonds with the docked DNA receptor. One of the phenyl attached N-H in 3 interacted with the oxygen of C=O of DT-20 and nitrogen of DA-6 to form two hydrogen bonds. Furthermore, indole N-H interacted with the oxygen of C=O of DT-8 and formed a hydrogen bond [78] . Interactions of all the Ni(II) complexes with the B-DNA receptor are shown in Fig S6. Docking studies revealed the efficient binding of the Ni(II) complexes with the DNA. This might disturb the stability of the DNA, which could trigger the DNA cleavage. Notably, molecular docking study was performed to predict the binding affinity and the sterically favourable conformations of the Ni(II) complexes towards DNA without considering the intercalation [79] . As molecular docking study considered only minor groove binding and experimental findings proposed intercalation of the complexes with DNA, no attempt was made to correlate the results of docking and experimental studies.
In the human DNA topoisomerase I complex (PDB ID: 1SC7), Topo-I was bound to the oligonucleotide sequence 50-AAAAAGACTTsX-GAAAATTTTT-30 in which 's' was 50-bridging phosphorothioate of the cleaved strand and 'X' represented any of the four bases A, G, C or T. The SH of G11 on the scissile strand was changed to OH and phosphoester bond of G12 in 1SC7 was rebuilt [80] . Molecular docking studies with DNA topoisomerase I clearly showed that the Ni(II) complexes approached towards the DNA cleavage site to form a stable complex which resulted in the binding energy between −9.29 and −12.80 kcal/mol Fig. S7 . Docking studies of the complexes with 3V03 receptor showed that all the docked compounds bound efficiently with the receptor and exhibited free energy of binding value from −7.24 to −8.07 kcal/mol. The previously reported binding site in BSA was taken for this study [81] . 
Antioxidant activity
Reactive oxygen species cause oxidative damage to the cellular tissues and initiates various disorders. Due to this, there is an increasing interest in antioxidants, particularly in those intended to prevent the adverse effects of free radicals in the human body. In this regard, the Ni(II) complexes were studied for their antioxidant potential using DPPH scavenging assay. DPPH reacts with antioxidant compound which donates hydrogen and reduces the DPPH radical. The change in colour was measured at 517 nm. From the assay it was found that the IC 50 value of 1 and 2 was about 75 µg/mL. The IC 50 value of 3 and 4 was found to be 50 and 500 µg/mL, respectively. The results clearly showed that 3 was more potent radical scavenger compared to the other three complexes (1, 2 and 4) , which might be due to the electron withdrawing effect of the phenyl group on the terminal nitrogen atom [82] . The results are shown in Fig. S9 .
Haemolysis assay
Ni(II) complexes (1-4) were tested for their toxicity against human RBC. From the results it was clearly inferred that the Ni(II) complexes (1-4) did not induce any haemolysis (Fig.  S10) . The results were compared to the control cells treated with water which produced 100% lysis. The results suggested that the Ni(II) complexes (1-4) could be used further as they did not show any toxicity against RBC [83] .
In vitro cytotoxicity
The positive results obtained from the DNA and protein binding studies exhilarated us to test the cytotoxicity of the complexes (1-4). It was carried out against lung (A549) cancer, human breast (MCF7) cancer and mouse fibroblasts (L929) cell lines using MTT assay [84] . Figure S11 shows the cytotoxicity of the complexes (1-4) after 24 h incubation on A549, MCF7 and L929 cell lines, respectively. Complexes were dissolved in DMSO and a blank sample containing the same volume of DMSO was taken as a control to identify the activity of the solvent in this experiment. Cisplatin was used as a positive control to assess the cytotoxicity of the tested complexes. The results were analysed by means of cell inhibition expressed as IC 50 values and are shown in Table 6 . Figures S12 and S13 show digital images of the cancer cells (A549 and MCF7) and the cancer cells treated with the complexes (1-4) . The IC 50 values showed that complexes 4 and 1 exhibited higher inhibitory effect than that of the other complexes and the IC 50 was close to that of cisplatin. Fortunately, all the complexes were less toxic towards the normal cell (L929) as it was evident from the higher IC 50 values (600-750 µM) ( Table 6 ). The cytotoxicity results are in good agreement with DNA binding ability of the complexes. Cytotoxicity of the nickel(II) complexes was compared with that of previously reported square planar nickel(II) complexes (Fig. 7) . The present Ni(II) complexes showed higher activity than some of the other reported nickel(II) complexes. The cytotoxicity of nickel(II) complexes containing l-proline-and l-homoproline-4-N-pyrrolidine-3-thiosemicarbazone hybrid ligand showed IC 50 value around 222.6 ± 17.1 μM against the A549 (96 h of incubation) cancer cell line [85] . The ionic square planar nickel complex bearing 4-chloro-5-methyl-salicylaldehyde thiosemicarbazone ligand showed higher cytotoxicity with lower IC 50 (<10 μM) value against A549 (48 h of incubation) cancer cell line [16] . In vitro cytotoxicity of the Ni(II) complexes with substituted thiosemicarbazone ligands was good (IC 50 = 25-30 μM) against human lung adenocarcinoma (A549) cell line, which was comparable with the Fig. 7 [88] . It is well evident from the comparison that our complexes showed high cytotoxicity. However, our complexes are less effective compared to cisplatin. 
Hoechst staining
Many antitumor agents used in chemotherapy are based on their ability to induce apoptosis in cancer cells [89, 90] . So the molecular mechanism of cell death has been studied by treating the complexes with the lung (A549) and human breast (MCF7) cancer cells. IC 50 concentration of the Ni(II) complex (4) was used for the staining assay. The complex was incubated for 24 h and it was observed for cytological changes by adopting Hoechst 33258 staining. The results revealed that the cell death mechanism was apoptosis ( Fig. 8 ) [91] .
Conclusions
Four indole-based thiosemicarbazone ligands and their Ni(II) complexes were synthesized and characterized with a view to evaluate their biological applications. The complexes (1-4) bound to DNA via intercalation. Binding affinity of all the Ni(II) complexes with BSA was significant and the complexes bound to BSA in both tyrosine and tryptophan residues. The docked models also confirmed the binding affinity of the Ni(II) complexes with targeted DNA/protein. In addition, the complexes possess significant antioxidant activity. The haemolysis results revealed that the Ni(II) complexes (1-4) could be used for further pharmacological studies. The complexes showed high cytotoxicity against human lung (A549) and human breast (MCF7) cancer cell lines. DNA/protein binding and DNA cleavage ability of the complexes followed the order 4 > 3 > 1 > 2. Cytotoxic property of the complexes was in different order towards A549 and MCF7, but 4 exhibited pronounced activity against both the cell lines. The high cytotoxicity of 4 might be due to the presence of bulky substitution (cyclohexyl) at the terminal nitrogen atom of the ligand. But the activity of the complexes was less compared to cisplatin. It is a convincing factor that there are reports on complexes having higher IC 50 values than cisplatin (in vitro) showed significant activity in vivo [92, 93] . Apoptosis mechanism for the cell death was also confirmed. 
